Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Forte Biosciences, Inc. (FBRX) had four reporting persons—Tybourne Capital Management (HK) Limited, Tybourne Strategic Opportunities GP II Limited, Tybourne Kesari Limited and Viswanathan Krishnan—reporting 0 shares of its common stock beneficially owned, equal to 0.00% of the class. The securities had previously been held for accounts of private investment funds managed by Tybourne Capital Management (HK) Limited, with Tybourne Strategic Opportunities GP II Limited as general partner.
Key Figures
Common shares beneficially owned:0 sharesPercent of class beneficially owned:0.00%Sole voting power:0 shares+3 more
6 metrics
Common shares beneficially owned0 sharesReported by each of the four reporting persons
Percent of class beneficially owned0.00%Reported ownership percentage
Sole voting power0 sharesReported voting power
Shared voting power0 sharesReported voting power
Sole dispositive power0 sharesReported power to dispose of shares
Shared dispositive power0 sharesReported power to dispose of shares
Key Terms
beneficially owned, sole power to vote, dispositive power
3 terms
beneficially ownedregulatory
"Amount beneficially owned: 0 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole power to voteregulatory
"Sole power to vote or to direct the vote"
dispositive powerregulatory
"Sole power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many FBRX shares did the reporting persons beneficially own?
The four reporting persons reported 0 FBRX common shares beneficially owned, or 0.00% of the class.
Who managed the private funds that previously held FBRX stock?
Tybourne Capital Management (HK) Limited was identified as investment manager and Tybourne Strategic Opportunities GP II Limited as general partner. Tybourne Kesari Limited was the parent of both, and Viswanathan Krishnan was its principal and sole shareholder.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Forte Biosciences, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
34962G208
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
34962G208
1
Names of Reporting Persons
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
HONG KONG
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
CUSIP Number(s):
34962G208
1
Names of Reporting Persons
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
CUSIP Number(s):
34962G208
1
Names of Reporting Persons
Tybourne Kesari Ltd
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
34962G208
1
Names of Reporting Persons
Krishnan Viswanathan
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED KINGDOM
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN, HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Forte Biosciences, Inc.
(b)
Address of issuer's principal executive offices:
3060 PEGASUS PARK DRIVE, BUILDING 6, DALLAS, Texas, 75247
Item 2.
(a)
Name of person filing:
This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"):
i) Tybourne Capital Management (HK) Limited ("Tybourne HK");
ii) Tybourne Strategic Opportunities GP II Limited (the "GP")
iii) Tybourne Kesari Limited ("Tybourne Kesari"); and
iv) Viswanathan Krishnan ("Mr. Krishnan")
This statement relates to securities previously held for the accounts of private investment funds (the "Private Funds") for which Tybourne HK serves as investment manager and for which the GP serves as general partner. Tybourne Kesari is the parent of Tybourne HK and the GP. Mr. Krishnan is the principal and sole shareholder of Tybourne Kesari. In such capacities, Tybourne HK, the GP, Tybourne Kesari and Mr. Krishnan may have been deemed to have voting and dispositive power over securities held for the Private Funds. Tybourne Capital Management Limited, a former Reporting Person, is no longer an investment advisor for the Private Funds.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each Tybourne HK and Mr. Krishnan is Suites 818-822, B/F, Bank of America Tower, 12 Harcourt Road, Hong Kong. The address of the registered office of each of the GP and Tybourne Kesari is c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY 1-1104, Cayman Islands.
(c)
Citizenship:
i) Tybourne HK is a company incorporated in Hong Kong with limited liability,
ii) the GP is a company incorporated in the Cayman Islands with limited liability,
iii) Tybourne Kesari is organized in the Cayman Islands, and
iv) Mr. Krishnan is a citizen of the United Kingdom.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
34962G208
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Investment adviser registered with the Hong Kong Securities and Futures Commission
Item 4.
Ownership
(a)
Amount beneficially owned:
0 shares
(b)
Percent of class:
0.00%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
0 shares
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
0 shares
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See disclosure in Item 2 hereof.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Signature:
/s/ Charlotte Fung
Name/Title:
Charlotte Fung, Chief Operating Officer
Date:
11/04/2026
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED
Signature:
/s/ Viswanathan Krishnan
Name/Title:
Viswanathan Krishnan, Director
Date:
11/04/2026
Tybourne Kesari Ltd
Signature:
/s/ Viswanathan Krishnan
Name/Title:
Viswanathan Krishnan, Principal
Date:
11/04/2026
Krishnan Viswanathan
Signature:
/s/ Viswanathan Krishnan
Name/Title:
Viswanathan Krishnan, Individually
Date:
11/04/2026
Exhibit Information
99.1 Joint Filing Agreement, executed by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on February 14, 2024
